<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE8BE5A2-BC84-41EB-AC11-3CABE3963839"><gtr:id>FE8BE5A2-BC84-41EB-AC11-3CABE3963839</gtr:id><gtr:name>Sandia Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Mathematics</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D"><gtr:id>E34FA4DB-FD6C-4477-82AA-F9FFBC04D84D</gtr:id><gtr:name>Kiel University</gtr:name><gtr:address><gtr:line1>Kiel University</gtr:line1><gtr:line2>Christian Albrechts Platz 4</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE8BE5A2-BC84-41EB-AC11-3CABE3963839"><gtr:id>FE8BE5A2-BC84-41EB-AC11-3CABE3963839</gtr:id><gtr:name>Sandia Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6184714F-C2F9-4D4A-BF81-55F6159D64AE"><gtr:id>6184714F-C2F9-4D4A-BF81-55F6159D64AE</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Eric</gtr:otherNames><gtr:surname>Beardmore</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802611"><gtr:id>B0E54ABE-E62D-4203-ACE3-99446515DFAE</gtr:id><gtr:title>The Optimal Deployment of Antibiotics: Whether, How and When to Switch</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802611</gtr:grantReference><gtr:abstractText>Optimal control is a term used to describe the research that made much of the space-race possible. Neil Armstrong s moon landing was made possible by understanding how to manipulate a space rocket with minimal fuel expenditure. The idea behind this work is to take the same basic engineering science and to apply it by asking whether the evolution of resistance that blights antibiotic treatments can be somehow minimised by understanding how to deploy those antibiotics in an optimal way.

We can already do this, in theoretical terms, and we are able to create weird and wonderful ways of deploying antibiotic to a biological system in order to maximise its health. However, a lot of biological theory based on mathematical modeling has been proposed in the past that turned out to be plain wrong when the right experiments were done. This is especially true of population biology, the branch of biology that treats interacting populations of organisms such as microbes and other cells. Now, the mathematical modeling in this work is a mix of population biology, cell biology and genetics; while space researchers have Newton s laws to lean on, population biology has no intrinsic, physical laws. As a result, it is sometimes a feature of the field that theoretical concepts stick before they are truly tested. So, we want to test our theories to destruction to make sure they work in the lab before we eventually go on to try and persuade medical practitonners that cycling different antibiotics is a good thing to do. Certainly, it is better to cycle than to mix them into a single treatment, at least that s what our theories always say. This research will go a long way to proving that what works in theory, also works in the lab, and hopefully in practise too.</gtr:abstractText><gtr:technicalSummary>The fields of mathematical modeling and evolving microbial microcosms provides a success
story in how cellular and population-level theoretical modeling can come together to
provide new insights and theories of how the most populous organisms on the planet, and
indeed in our own bodies, microbes, evolve in time.

I am a member of two networks seeking to exploit this synergy, MEMMS
(http://www.mmems.org/) and DIMME (via http://www.nescent.org) where antibiotic
resistance is seen as one of the most important of all challenges and I propose that
appropriately targeted mathematics, when built around new experimental research, can make
a real difference to this field.

In their review Antibiotic cycling or rotation: a systematic review of the evidence of
efficacy , Antimicrobial Chemotherapy, 2005, Brown and Nathwani pose numerous questions
regarding the efficacy of cycling different antibiotics in an antimicrobial treatment. Is
the order of rotation critical? and What is the optimal duration of each cycle? They
indicate that the evidence is sparse as to whether one should cycle antibiotics, or mix
them in an ideal treatment.

Mathematical and microbial modelling can answer questions like these, provided the
correct experimental, theoretical and computational techniques are used. So, yes, indeed,
the order of rotation is critical, moreover periodic cycling or rotation will almost
never provide the best treatments. We can show that the deployment of antibiotics to
laboratory systems should be based on some form of non-periodic, cycling treatment but
this is ongoing research based on an analysis of large classes of stochastic models of
evolving bacterial microcosms in continuous culture.

The idea of this first, theoretical aspect of the project is not to minimise antibiotic
usage, rather it is directed at better understanding how one can ascribe a numerical
 health state or measure to an ecosystem, such as that found in a mammalian gut, and
to then find a deployment protocol for the antibiotics to maximise that measure.

The second part of this research project is to use microbial models to test this very
robust theoretical conclusion that in turn provides a very clear structure for
experimental design based on choosing antibiotic switching times and deployment
concentrations. For this, I am seeking some funding to undertake experimental work and
conduct the experiments with a collaborator in a lab at Oxford University s Zoology
Department using the human pathogen Pseudomonas aeruginosa and two bacteriostatic
antibiotics.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>89971</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sandia Laboratories</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Frink and Sandia Labs - fluids DFT</gtr:description><gtr:id>9E0F9D74-A4EC-498C-86C0-7B915FE5C90A</gtr:id><gtr:impact>The collaboration (between mathematically-oriented scientists) was instrumental in two recent EPSRC awards totalling &amp;pound;1.1M of which one part was to have a PhD student use modern algorithms to study problems in the theory of adsorption.</gtr:impact><gtr:outcomeId>i1VN4whTi8V-1</gtr:outcomeId><gtr:partnerContribution>Sandia have offered training in HPC computational methods to a PhD student (funded by EPSRC) to apply classical/fluids density functional theory to study problems in molecular biology relating to the action of antibiotics. They will provide 3, 3-month placements in Albuquerque with travel expenses of the student covered by Sandia.</gtr:partnerContribution><gtr:piContribution>The development of algorithms to solve theoretical problems in soft condensed matter physics.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kiel</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Evolutionary Ecology and Genetics</gtr:department><gtr:description>Schuelenberg - Evolution of Antibiotic Resistance</gtr:description><gtr:id>7B9AE424-06B0-4CDC-9537-1124DF2909FF</gtr:id><gtr:impact>An interdisciplinary interaction between mathematicians and evolutionary geneticists: the main current output (due to the sort length of the collaboration that is due entirely to MRC DH funding) is a dataset on the adaptation of various bacteria to antibiotics. We expect this to lead (within 12 months) to a number of high profile publications as the initial results (available as yet in preprint form) are highly promising: we can &amp;quot;predict&amp;quot; certain drug interactions from their individual modes of action.</gtr:impact><gtr:outcomeId>eZg1RDVtqk9-1</gtr:outcomeId><gtr:partnerContribution>They (with input on experimental design and data analysis tasks from my group) have provided a dataset on the adaptation of P. aeruginosa, E.coli and MRSA to a series of broad-spectrum antibiotics. This dataset has allowed us to develop mathematical models that can predict interactions between drugs (at the moment for rifampicin, erythromycin and doxycycline) from information on their modes of action. We are now applying these models (that blend evolutionary genetics and systems biological approaches) to produce hindcasts of robot-based evolutionary experiments. A number of future experimental collaborations are planned to build on this, including the use of robots (programmed by us) to improve the quality of the data. We plan to share a German PhD student (David Laehnemann, currently an UG member of the group) hosted by Kiel to manage the day-to-day operation of the work.</gtr:partnerContribution><gtr:piContribution>performed experimental tasks (design/data analysis/model development)
provided training to UG students in mathematical modelling techniques</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ETH Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Ackermann - Microscopy for Cell Individuality</gtr:description><gtr:id>C9A3DCD5-7EEF-44E3-83E6-30A51C81EDC2</gtr:id><gtr:impact>A collaboration between mathematicians and evolutionary microbiologists: 2-d cell-tracking software written by us has led to the production of datasets of cell sizes and division rates as a function of time and antibiotic concentration.

This collaboration has led to me organising a forthcoming international meeting on the mathematical modelling of antimicrobials. For information on this meeting visit 
http://www.mmems.org/index.php?id_pag=13</gtr:impact><gtr:outcomeId>k3QCtWW8J1f-1</gtr:outcomeId><gtr:partnerContribution>Prof Martin Ackermann has offered to our group training in the use of confocal microscopy to study single-cell responses to antibiotics. This is a new collaboration aimed at understanding the response of individual cells to antibiotics in a growing, colony of bacteria.</gtr:partnerContribution><gtr:piContribution>Undertaken image analyses (and written software) to track cells (sizes, pole locations) within growing colonies up to 100/1000 cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Ecology and Evolutionary Biology</gtr:department><gtr:description>Lenski/Mayer - Evolution of Phage Resistance</gtr:description><gtr:id>BD43F508-FFA8-488B-BB42-8F210DB16F94</gtr:id><gtr:impact>Collaboration between evolutionary biologists and mathematicians: the output consists of an ongoing collaboration highly likely to lead to a publication within 12 months on the prediction of evolution of a virus to its host, with the aim of understanding how the genetic diversity of responses is mediated by environmental conditions.</gtr:impact><gtr:outcomeId>GJLpjeg6jDV-1</gtr:outcomeId><gtr:partnerContribution>They have provided two experimental datasets concerning the adaptation of the lambda phage to the lamB maltoporin on E.coli: one concerns binding affinities of the virus to the host receptor, the other concerns co-adapation of host and virus in a 21-day experimental protocol.</gtr:partnerContribution><gtr:piContribution>image analysis/processing creating a dataset from raw experimental images;
predictive modelling (blending evolutionary genetics and system biology approaches) of the E.coli lamB receptor and its adaptation to the virus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>989446</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Leadership Fellowship EP/I00503X/1 Bacteriophage and Antibiotic Resistance: a Mathematical and Imaging Approach</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/I00503X/1</gtr:fundingRef><gtr:id>DC3C0AEB-CA01-4944-9DE5-624A04CD5DEB</gtr:id><gtr:outcomeId>beCm3H72ZG40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83702</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC C-DIP Award</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/I018263/1</gtr:fundingRef><gtr:id>FC581D1B-579F-4F3D-B143-C97450C2F5BD</gtr:id><gtr:outcomeId>fNK5VrbEBBE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed algorithms using the Java-based package ImageJ to analyse images of experimental assays (typically conducted on 96-well microtiter plates) to determine the adsorption properties of viral phage to bacteria.
In collaboration with Justin Meyer and Richard Lenski, we have applied this tool to determine the adsorption matrix of around 100 E.coli B with mutations in lamB with respect to around 50 lambda virus mutants.
This information is of importance in evolutionary ecology where it is believed that host-pathogen interaction genetics occur through mechanisms commonly called &amp;quot;gene-for-gene&amp;quot; or &amp;quot;matching alleles&amp;quot;. This dataset shows this to be untrue for E.coli and lambda interactions.</gtr:description><gtr:id>BFE9938A-83B8-4172-9986-3D478B2658F9</gtr:id><gtr:impact>This has lead to an ongoing collaboration whereby lambda and Ecoli are to be co-evolved to understand whether their interaction genetics is sufficient to be able to predict their coevolution over 100-200 generations. We have predicted &amp;quot;patterns&amp;quot; of lamB polymorphism across different bacterial micro-environments (controlled by the supply of maltotriose) and we will soon conduct these experiments to relate our mathematical predictions to the biology.</gtr:impact><gtr:outcomeId>C7BUtUcnBU8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Imaging for Phage Binding Assays</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Microbial inhibition curves are classically fitted as Hill functions to optical density or CFU data. We developed a technique that produces a theoretical inhibition curve by fitting a mechanistic model to a drug-free environment and predicting inhibition curves from the mode of action of the drug. When this is done for multiple drugs we can predict the interaction of the drug pair (synergistic, antagonistic or otherwise) by knowing something of the way the drugs bind to their respective targets.
During the 12-month project we performed this analysis for the drug erythromycin and doxycycline as inhibitors of E.coli in microtiter well plates, but we are extending the technique (without modification) to other pathogens, drugs and are modifying it for yeast/fluconazol.</gtr:description><gtr:id>F0836D50-B3B1-48FF-8AE7-B095CBC3F885</gtr:id><gtr:impact>The technique described will be used to predict not only drug interactions, but to use theoretical techniques to deduce optimal drug combinations against a number of criteria for a culture lasting one-two weeks (50-100 microbial generations). While this remains future work, we have used these models to hypothesise that synergistic drug interactions select so strongly for multi-drug resistance that synergistic combinations are best deployed as sequential (non-combination) therapies.
It is only the short duration of the Discipline Hopping award that has prevented us from performing the evolutionary experiments to test these hypotheses, having had to master the experimental techniques and develop new modelling techniques to both generate and analyse this dataset. However, this project will continue to completion and would not have been possible without the DH award.</gtr:impact><gtr:outcomeId>XnPNRXJWtWu</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Drug inhibition curves</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have used ImageJ to track individual cell lineages in growing colonies. Packages already exist for this purpose, we implemented one in ImageJ to improve the accuracy and reliability (reducing the need for human intervention).</gtr:description><gtr:id>7AA8B1F0-C2D3-4306-9B01-5D899F7918EE</gtr:id><gtr:impact>As a result of these algorithms, we have started a project with Martin Ackermann to track cells in growing colonies and to determine statistics on cell division times as a function of antibiotic concentration. We have a hypothesis that the MIC (minimal inhibitory concentration) is an illusory population-level, collective artefact and not recognised by individual cells. This, and similar analysis tools developed by us, will be used to probe this hypothesis using individual cells of E.coli and a C.crescentus system developed previously by Ackermann.</gtr:impact><gtr:outcomeId>MZ5BZSyZXfG</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cell Tracking</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2DD10B81-1318-471E-A28E-9E1D2183928C</gtr:id><gtr:title>The optimal deployment of synergistic antibiotics: a control-theoretic approach.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a581bc3738efff51a5a77c133b08b3e1"><gtr:id>a581bc3738efff51a5a77c133b08b3e1</gtr:id><gtr:otherNames>Pe?a-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>pm_15808_28_22628215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EAA97A8-3DBD-40F9-A0D5-C93E9B81FEC9</gtr:id><gtr:title>Metabolic trade-offs and the maintenance of the fittest and the flattest.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>QU3G9uG1CdP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A3DAA7F-965E-40C4-A739-C6B9688D4D8A</gtr:id><gtr:title>Rotating antibiotics selects optimally against antibiotic resistance, in theory.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences and engineering : MBE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-1063</gtr:issn><gtr:outcomeId>hn1oNcjESKq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD0581D-0D3C-4DC4-A7BA-61DCD6C59FC3</gtr:id><gtr:title>Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences and engineering : MBE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f857b8b470160d6707934a1b8cf8f80"><gtr:id>8f857b8b470160d6707934a1b8cf8f80</gtr:id><gtr:otherNames>Beardmore RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-1063</gtr:issn><gtr:outcomeId>QCB54djUjVx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B98808B5-319A-4050-9866-AC303F6275F5</gtr:id><gtr:title>Bistable expression of virulence genes in salmonella leads to the formation of an antibiotic-tolerant subpopulation.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/180c5290d5174d25b4bda49292759969"><gtr:id>180c5290d5174d25b4bda49292759969</gtr:id><gtr:otherNames>Arnoldini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>546388ba5c2231.76508873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA80918D-00F5-4651-BFCC-8CBF790A77AA</gtr:id><gtr:title>Selecting against antibiotic-resistant pathogens: optimal treatments in the presence of commensal bacteria.</gtr:title><gtr:parentPublicationTitle>Bulletin of mathematical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a581bc3738efff51a5a77c133b08b3e1"><gtr:id>a581bc3738efff51a5a77c133b08b3e1</gtr:id><gtr:otherNames>Pe?a-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8240</gtr:issn><gtr:outcomeId>pm_15808_28_22057950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF3161F-21FD-4B2C-8B14-3053B1E537FD</gtr:id><gtr:title>When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1ce8cdbd2c070490543cfed04941c1"><gtr:id>bc1ce8cdbd2c070490543cfed04941c1</gtr:id><gtr:otherNames>Pena-Miller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>doi_15808_io_1001540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DE738EA-7479-4BF5-AE12-B7D7586BBF72</gtr:id><gtr:title>Classifying the role of trade-offs in the evolutionary diversity of pathogens</gtr:title><gtr:parentPublicationTitle>Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82e2d6921c08231bb6be490bf53643dd"><gtr:id>82e2d6921c08231bb6be490bf53643dd</gtr:id><gtr:otherNames>Beardmore R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>doi_55f94594514c1cce</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6138BA9-0676-4FCA-9FF3-397C2EF0CA9C</gtr:id><gtr:title>The form of a trade-off determines the response to competition.</gtr:title><gtr:parentPublicationTitle>Ecology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5d05cef4dfae64fd24a51f41c3053f1"><gtr:id>c5d05cef4dfae64fd24a51f41c3053f1</gtr:id><gtr:otherNames>Maharjan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1461-023X</gtr:issn><gtr:outcomeId>doi_15808__ele_12159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E4B8343-A80F-4FA4-9651-FA3DCFD2E395</gtr:id><gtr:title>Genomics of Rapid Adaptation to Antibiotics: Convergent Evolution and Scalable Sequence Amplification</gtr:title><gtr:parentPublicationTitle>Genome Biology and Evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/829b4ebe6eab021eafdb1bc4eb2e95cb"><gtr:id>829b4ebe6eab021eafdb1bc4eb2e95cb</gtr:id><gtr:otherNames>Laehnemann D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn><gtr:outcomeId>546388f9d44e61.08420143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4979D83-05CD-4D16-B494-3BE10457B0C7</gtr:id><gtr:title>Understanding the limits to generalizability of experimental evolutionary models.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1214ed53859ac7c091771cc0530b5c65"><gtr:id>1214ed53859ac7c091771cc0530b5c65</gtr:id><gtr:otherNames>Forde SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>UUBRze4AXoW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30706D82-6FBB-478B-A8C5-6ED657F04865</gtr:id><gtr:title>Constraints on microbial metabolism drive evolutionary diversification in homogeneous environments.</gtr:title><gtr:parentPublicationTitle>Journal of evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f2335af6dac36afd9a798fb54b16d"><gtr:id>7b9f2335af6dac36afd9a798fb54b16d</gtr:id><gtr:otherNames>Gudelj I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1010-061X</gtr:issn><gtr:outcomeId>HADM4EoWhmV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5177C0EC-D30C-4980-BA88-B9F402193441</gtr:id><gtr:title>Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a5d101c90c15f6eb106ba4cdee52a1d"><gtr:id>3a5d101c90c15f6eb106ba4cdee52a1d</gtr:id><gtr:otherNames>Peters R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>NDqLP9ow7nQ</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802611</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>